Statistical Parametric Mapping in Amyloid Positron Emission Tomography

Alzheimer’s disease (AD), the most common cause of dementia, has limited treatment options. Emerging disease modifying therapies are targeted at clearing amyloid-β (Aβ) aggregates and slowing the rate of amyloid deposition. However, amyloid burden is not routinely evaluated quantitatively for purpos...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Natasha M. Smith, Jeremy N. Ford, Arsalan Haghdel, Lidia Glodzik, Yi Li, Debra D’Angelo, Arindam RoyChoudhury, Xiuyuan Wang, Kaj Blennow, Mony J. de Leon, Jana Ivanidze
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2022-04-01
Edice:Frontiers in Aging Neuroscience
Témata:
SPM
PET
Alzheimer’s disease
dementia
amyloid
On-line přístup:https://www.frontiersin.org/articles/10.3389/fnagi.2022.849932/full
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky